Radiation-induced xerostomia: is octreotide the solution?
Octreotide acted as a radioprotective agent on rat parotid glands 1 month after irradiation with 30 Gy given with the gamma knife.
Patients with poor device acceptance and Type D personality should be identified and monitored in clinical practice, as they may benefit from adjunctive intervention in order to experience the same quality of life benefits following implantation as other patients. Given the cross-sectional nature of the study, these findings should be confirmed using a prospective study design.